Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand (2007)

Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis

for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand

Yot Teerawattananon¹         Miranda Mugford²         Viroj Tangcharoensathien¹

¹Ministry of Public Health, Nonthaburi, Thailand

²University of East Anglia, Norwich, UK

Objective: To examine the value for money of including peritoneal dialysis (PD) or hemodialysis (HD) into the universal health insurance scheme of Thailand.
Methods: A probabilistic Markov model applied to endstage renal disease (ESRD) patients aged 20 to 70 years was developed to examine the incremental cost-effectiveness
ratio (ICER) of palliative care versus 1) providing PD as an initial treatment followed by HD if complications/switching occur; and 2) providing HD followed by PD if complications/
switching occur. Input parameters were extracted from a national cohort, the Thailand Renal Replacement Therapy Registry, and systematic reviews, where possible.
The study explored the effects of uncertainty around input parameters, presented as cost-effectiveness acceptability frontier, as well as the value of obtaining further information
on chosen parameters, i.e., partial expected value of perfect information.
Results: Using a societal perspective, the average ICER of initial treatment with PD and the average ICER of initial treatment with HD were 672,000 and 806,000 Baht per
quality-adjusted life-year (QALY) gained (52,000 and 63,000 purchasing power parity [PPP] US$/QALY) compared with palliative care. Providing treatments for younger ESRD patients resulted in a significant improvement of survival and gain of QALYs compared with the older aged
group. The cost-effectiveness and cost-utility ratios of both options for the older age group were relatively similar.
Conclusions: The results suggest that offering PD as initial treatment was a better choice than offering HD, but it would only be considered a cost-effective strategy if the social willingness-to-pay threshold was at or higher than 700,000 Baht per QALY (54,000 PPP US$/QALY) for the age 20 group and 750,000 Baht per QALY (58,000 PPP US$/QALY) for age
70 years.

Keywords: dialysis, economic evaluation, renal failure, Thailand, value of information.

Link:  http://www.valueinhealthjournal.com/article/S1098-3015%2810%2960455-X/abstract

http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2006.00145.x/abstract